Q4 2025 Holdings
Filed 2026-02-17 | 461 holdings | $367.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alumis Inc(ALMS) | COM | 022307102 | $226.0K | 23,153 | 0.1% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $229.1K | 73,896 | 0.1% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $230.1K | 2,897 | 0.1% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $230.8K | 2,966 | 0.1% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $231.0K | 22,318 | 0.1% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $231.4K | 20,463 | 0.1% |
| Savara Inc(SVRA) | COM | 805111101 | $231.8K | 38,443 | 0.1% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $232.0K | 28,361 | 0.1% |
| Monopar Therapeutics Inc(MNPR) | COM NEW | 61023L207 | $232.8K | 3,565 | 0.1% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $236.9K | 5,116 | 0.1% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $237.1K | 17,987 | 0.1% |
| Meiragtx Hldgs PLC(MGTX) | COM | G59665102 | $237.1K | 29,824 | 0.1% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $238.0K | 6,554 | 0.1% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $238.8K | 5,912 | 0.1% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $239.8K | 39,764 | 0.1% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $240.0K | 17,388 | 0.1% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $241.3K | 3,701 | 0.1% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $241.4K | 176,178 | 0.1% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $242.3K | 14,395 | 0.1% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $243.0K | 15,778 | 0.1% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $243.7K | 2,790 | 0.1% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $244.3K | 14,795 | 0.1% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $244.7K | 31,783 | 0.1% |
| Rapt Therapeutics Inc(RAPT) | COM NEW | 75382E208 | $244.8K | 7,229 | 0.1% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $245.2K | 25,679 | 0.1% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $245.3K | 20,307 | 0.1% |
| Xencor Inc(XNCR) | COM | 98401F105 | $246.5K | 16,103 | 0.1% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $250.0K | 5,676 | 0.1% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $250.4K | 74,311 | 0.1% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $250.5K | 7,142 | 0.1% |
| Assembly Biosciences Inc(ASMB) | COM NEW | 045396207 | $250.6K | 7,369 | 0.1% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $250.8K | 21,148 | 0.1% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $251.0K | 10,034 | 0.1% |
| Recursion Pharmaceuticals in(RXRX) | CL A | 75629V104 | $251.3K | 61,439 | 0.1% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $251.3K | 73,488 | 0.1% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $251.8K | 12,367 | 0.1% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $252.1K | 28,452 | 0.1% |
| Celcuity Inc(CELC) | COM | 15102K100 | $252.1K | 2,528 | 0.1% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $252.4K | 7,174 | 0.1% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $252.7K | 45,946 | 0.1% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $252.8K | 35,709 | 0.1% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $254.0K | 26,133 | 0.1% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $255.3K | 2,538 | 0.1% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $255.7K | 16,310 | 0.1% |
| Sionna Therapeutics Inc(SION) | COM | 829401108 | $255.9K | 6,220 | 0.1% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $256.0K | 10,069 | 0.1% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $256.2K | 8,233 | 0.1% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $259.2K | 20,408 | 0.1% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $259.2K | 7,913 | 0.1% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $260.2K | 6,315 | 0.1% |